HCLS1 and colorectal carcinoma: Further, our data from the functional study confirmed that the overexpression of HCLS1, EVI2B, and CD48 can reduce the ability of proliferation, migration, and invasion in CRC cells and significantly suppress CRC tumor growth in vivo.